The board of directors of Astec Lifesciences will meet on December 19 to consider a proposal to allot ₹10 crore worth equity shares on preferential basis to select persons/ entities. The board meet will also consider hiking of borrowing limits and creation of charges on the assets of the company. Shares of Astec Lifesciences closed at ₹107.20, down 1.47 per cent on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.